Navigation Links
Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths,,

Baycol is a prescription drug manufactured by Bayer Pharmaceuticals. Baycol, which was initially approved by the FDA, belongs to a statin group of drugs that lowers cholesterol by blocking enzymes that are essential in the synthesis of cholesterol in the body.

Bayer Pharmaceuticals has voluntarily recalled its cholesterol drug Baycol( cerivastatin ) because // it has been linked to approximately 50 deaths. Baycol can cause a muscular side effect called rhabdomyolysis – destroyed muscles cells are released into the bloodstream and cause severe muscle pain, fever, weakness and vomiting. This condition can also lead to kidney failure.

The FDA said fatal reports with Baycol had been reported most frequently when the drug was used at higher doses, in elderly patients, and especially when taken in combination with another cholesterol-lowering drug called gemfibrozil. It said patients taking Baycol should consult their physicians about switching to another medication to control their cholesterol agents. Pharmacies will be instructed to return the product to the manufacturer for a refund.

FDA announced that Bayer Pharmaceutical Division is voluntarily withdrawing Baycol from the U.S. market. Patients who are taking Baycol should discontinue Baycol and consult their physicians about switching to alternate medications to control their cholesterol levels.


'"/>




Page: 1

Related medicine news :

1. Bayer Wins Positive Response For Marketing Its Cancer Drug
2. Genomatix Licensed By Bayer Healthcare
3. Bayer to Market Biocon Insulin in China
4. Test for Esophageal Reflux Licensed to Bayer by University
5. Hospital Withdraws McDonalds Reward Scheme
6. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
7. Associated therapy for multiple myeloma
8. Associated scan for detecting ovarian cancer spread
9. Ginseng Associated with Pregnancy Risks
10. Enzyme Associated with Memory
11. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology: